INR:9800. rohit sharma qualification Eli Lilly's IL-23 antibody achieves Phase 3 clinical endpoint and significantly improves symptoms in patients with ...

“You can decrease your risk of colorectal cancer by improving your lifestyle,” said Molefi. “Regular exercise and a diet that includes lots of vegetables, fruits, and whole grains have been linked to ...

Teva Pharmaceutical Industries continues to impress investors with strong sales growth and promising development. Click here ...

In a year of pivotal gastroenterology research, these 10 articles were in a class of their own, according to Dr David Johnson ...

Inflammatory bowel disease (IBD), which includes conditions like Crohn's disease and ulcerative colitis, affects millions of ...

ORLANDO -- Utilization of a "total telemedicine pathway" for inflammatory bowel disease (IBD) surgery saved a considerable ...

A study by University of Michigan researchers may provide an explanation for why some patients with Crohn's disease continue ...

Undiagnosed or untreated EPI could result in muscle loss since the patient isn’t absorbing the necessary nutrients.

A new study may explain why some Crohn's disease patients still experience symptoms despite the absence of inflammation.

A study from University of Michigan researchers may provide an explanation for why some patients with Crohn's disease continue to experience symptoms, even in the absence of inflammation.

A study from University of Michigan researchers may provide an explanation for why some patients with Crohn's disease continue to experience symptoms ...

Hims stock skidded Thursday after the FDA determined Eli Lilly's tirzepatide — which sells as a weight-loss drug — is no longer in shortage.